Robert Burns Analyst PerformanceVice President of Equity Research at HC WainwrightRobert Burns is a stock analyst at HC Wainwright in the healthcare sector, covering 50 publicly traded companies. Over the past year, Robert Burns has issued 141 stock ratings, including buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings302 Last 6 YearsBuy Recommendations91.03% 274 Buy RatingsCompanies Covered50 Unique Companies Ratings Distribution301RatingsDistribution of strong buy, buy, hold, and sell ratings by Robert Burns.RatingPercentageCount Strong Buy0.3%1 ratings Buy90.7%273 ratings Hold8.3%25 ratings Sell0.7%2 ratingsOut of 301 total stock ratings issued by Robert Burns at HC Wainwright, the majority (90.7%) have been Buy recommendations, followed by 8.3% Hold, 0.7% Sell, and 0.3% Strong Buy.Best & Worst CallsBest Call000000.0%TNGXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%FATEJan 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ92.0% of companies on NASDAQ46 companiesNYSE4.0% of companies on NYSE2 companiesOTCMKTS2.0% of companies on OTCMKTS1 companyNYSEAMERICAN2.0% of companies on NYSEAMERICAN1 companyRobert Burns, an analyst at HC Wainwright, currently covers 50 companies listed on NASDAQ, NYSE, OTCMKTS and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare50 companies100.0%Robert Burns of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY47 companies94.0%PHARMACEUTICALS3 companies6.0% About Robert BurnsMr. Burns is a Vice President of Equity Research at H.C. Wainwright whose research focuses on the biotechnology sector. Mr. Burns’ expertise spans the universe of next-generation approaches to the treatment of cancer, with particular focus on the immuno-oncology and precision oncology sectors. Prior to joining H.C. Wainwright, Mr. Burns worked at BMO Capital Markets as an equity research associate covering Major Pharma under analyst Alex Arfaei; he followed multiple Top 10 pharmaceutical firms and focused on tracking developments in the oncology arena, particularly within the context of checkpoint inhibition and immunotherapy. Mr. Burns’ educational background includes a Master’s degree in Medical Science from Boston University School of Medicine as well as a Bachelor’s degree in Chemistry from Brooklyn College. Mr. Burns also attended Boston University School of Medicine as a medical student for three years.Follow on LinkedIn Robert Burns' Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsKPTIKaryopharm Therapeutics7/31/2026Downgrade$7.01Negative$0.0000.00% ROIKPTIKaryopharm Therapeutics7/31/2026Reiterated Rating$7.01$3.00Neutral$0.0000.00% ROIPRLDPrelude Therapeutics7/29/2026Reiterated Rating$4.64$8.00Buy$0.0000.00% ROITLPPFTelix Pharmaceuticals7/28/2026Reiterated Rating$10.02Buy$0.0000.00% ROINUVBNuvation Bio7/27/2026Boost Price Target$6.45$21.00Buy$0.0000.00% ROIOKUROnKure Therapeutics7/20/2026Lower Price Target$4.18$21.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics7/15/2026Reiterated Rating$4.39Buy$0.0000.00% ROINRIXNurix Therapeutics7/10/2026Boost Price Target$24.69$34.00Buy$0.0000.00% ROIELVNEnliven Therapeutics7/9/2026Boost Price Target$50.80$64.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals7/7/2026Reiterated Rating$12.15$20.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MOLNMolecular Partners7/6/2026Reiterated Rating$3.98Buy$0.0000.00% ROIRVMDRevolution Medicines7/6/2026Reiterated Rating$190.26$195.00Buy$0.0000.00% ROIEXELExelixis7/2/2026Reiterated Rating$53.96$56.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics6/18/2026Reiterated Rating$9.40Buy$0.0000.00% ROIELTXElicio Therapeutics6/15/2026Boost Price Target$14.85$23.00Buy$0.0000.00% ROINRIXNurix Therapeutics6/10/2026Reiterated Rating$15.64$32.00Buy$0.0000.00% ROITNGXTango Therapeutics6/9/2026Boost Price Target$31.12$66.00Buy$0.0000.00% ROIADCTADC Therapeutics6/8/2026Downgrade$1.03Neutral$0.0000.00% ROIORICOric Pharmaceuticals6/8/2026Reiterated Rating$7.50$25.00Buy$0.0000.00% ROIFATEFate Therapeutics6/8/2026Reiterated Rating$1.98$7.00Buy$0.0000.00% ROICGEMCullinan Therapeutics6/8/2026Reiterated Rating$13.51$30.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics6/4/2026Initiated Coverage$4.49$6.00Buy$0.0000.00% ROIZYMEZymeworks6/3/2026Reiterated Rating$24.11$46.00Buy$0.0000.00% ROIAKTSAktis Oncology6/2/2026Boost Price Target$19.81$35.00Buy$0.0000.00% ROIRVMDRevolution Medicines6/1/2026Boost Price Target$163.40$195.00Buy$0.0000.00% ROICRDFCardiff Oncology6/1/2026Downgrade$1.90Neutral$0.0000.00% ROIELTXElicio Therapeutics5/28/2026Reiterated Rating$10.77$17.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics5/28/2026Reiterated Rating$5.28$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics5/26/2026Boost Price Target$13.53$28.00Buy$0.0000.00% ROIIMMXImmix Biopharma5/22/2026Boost Price Target$8.90$20.00Buy$0.0000.00% ROICRBUCaribou Biosciences5/11/2026Boost Price Target$1.94$11.00Buy$0.0000.00% ROIEXELExelixis5/7/2026Boost Price Target$48.70$56.00Buy$0.0000.00% ROICOGTCogent Biosciences5/6/2026Boost Price Target$36.97$55.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics5/6/2026Boost Price Target$9.41$13.00Buy$0.0000.00% ROIADCTADC Therapeutics5/5/2026Reiterated Rating$3.64$8.00Buy$0.0000.00% ROINUVBNuvation Bio5/5/2026Reiterated Rating$4.45$17.00Buy$0.0000.00% ROIFATEFate Therapeutics5/4/2026Boost Price Target$1.53$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics4/29/2026Boost Price Target$13.03$25.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics4/29/2026Boost Price Target$2.70$11.00Buy$0.0000.00% ROICGEMCullinan Therapeutics4/28/2026Boost Price Target$12.85$30.00Buy$0.0000.00% ROIPorter flew 3,300 miles to investigate this system (Ad)Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.Watch the full investigation and decide for yourselfPRLDPrelude Therapeutics4/27/2026Boost Price Target$4.70$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/27/2026Reiterated Rating$16.68$32.00Buy$0.0000.00% ROIBNTXBioNTech4/27/2026Reiterated Rating$105.46$130.00Buy$0.0000.00% ROIRVMDRevolution Medicines4/22/2026Reiterated Rating$148.90Buy$0.0000.00% ROIMOLNMolecular Partners4/22/2026Reiterated Rating$4.49$13.00Buy$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$3.04$12.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals4/13/2026Reiterated Rating$10.54$20.00Buy$0.0000.00% ROIREPLReplimune Group4/13/2026Reiterated Rating$4.77Sell$0.0000.00% ROINRIXNurix Therapeutics4/10/2026Reiterated Rating$16.24$32.00Buy$0.0000.00% ROICRBUCaribou Biosciences4/7/2026Reiterated Rating$1.95$9.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals4/7/2026Reiterated Rating$9.09$20.00Buy$0.0000.00% ROIORICOric Pharmaceuticals4/2/2026Reiterated Rating$7.47$25.00Buy$0.0000.00% ROIBNTXBioNTech3/31/2026Lower Price Target$85.25$130.00Buy$0.0000.00% ROIAKTSAktis Oncology3/31/2026Boost Price Target$16.54$33.00Buy$0.0000.00% ROIBCAXBicara Therapeutics3/31/2026Boost Price Target$19.04$42.00Buy$0.0000.00% ROIIMMXImmix Biopharma3/27/2026Boost Price Target$8.72$15.00Buy$0.0000.00% ROIELVNEnliven Therapeutics3/26/2026Boost Price Target$35.53$56.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics3/25/2026Lower Price Target$5.44$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics3/24/2026Reiterated Rating$14.69$32.00Buy$0.0000.00% ROIACETAdicet Bio3/23/2026Lower Price Target$6.92$27.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/23/2026Boost Price Target$9.91$19.00Buy$0.0000.00% ROIADCTADC Therapeutics3/23/2026Boost Price Target$3.88$8.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/23/2026Boost Price Target$4.45$13.00Buy$0.0000.00% ROIOKUROnKure Therapeutics3/16/2026Lower Price Target$3.78$27.00Buy$0.0000.00% ROIMOLNMolecular Partners3/16/2026Reiterated Rating$4.22$13.00Buy$0.0000.00% ROIELTXElicio Therapeutics3/13/2026Boost Price Target$10.90$17.00Buy$0.0000.00% ROIORICOric Pharmaceuticals3/13/2026Reiterated Rating$11.76$25.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics3/13/2026Reiterated Rating$4.05$7.00Buy$0.0000.00% ROIAKTSAktis Oncology3/9/2026Initiated Coverage$18.81$30.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/6/2026Boost Price Target$25.25$44.00Buy$0.0000.00% ROIBBOTBridgeBio Oncology Therapeutics3/6/2026Boost Price Target$9.89$29.00Buy$0.0000.00% ROITNGXTango Therapeutics3/6/2026Boost Price Target$16.80$27.00Buy$0.0000.00% ROIZYMEZymeworks3/6/2026Boost Price Target$24.80$46.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/24/2026Boost Price Target$12.46$25.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics2/18/2026Reiterated Rating$9.40$15.00Buy$0.0000.00% ROIEXELExelixis2/12/2026Boost Price Target$42.94$54.00Buy$0.0000.00% ROIEXELExelixis2/3/2026Reiterated Rating$42.81$52.00Buy$0.0000.00% ROIHURATuHURA Biosciences2/3/2026Reiterated Rating$0.52$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics1/30/2026Boost Price Target$4.26$12.00Buy$0.0000.00% ROINRIXNurix Therapeutics1/29/2026Boost Price Target$17.87$32.00Buy$0.0000.00% ROICRDFCardiff Oncology1/28/2026Reiterated Rating$2.00$10.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.09$13.00Buy$0.0000.00% ROIEXELExelixis1/27/2026Boost Price Target$43.61$52.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.00$13.00Buy$0.0000.00% ROIACETAdicet Bio1/21/2026Reiterated Rating$7.90$50.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals1/21/2026Reiterated Rating$7.73$20.00Buy$0.0000.00% ROIBCAXBicara Therapeutics1/14/2026Reiterated Rating$17.53Buy$0.0000.00% ROINUVBNuvation Bio1/12/2026Lower Price Target$8.03$17.00Buy$0.0000.00% ROIHURATuHURA Biosciences1/9/2026Reiterated Rating$0.75$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics1/8/2026Boost Price Target$10.71$27.00Buy$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techEXELExelixis1/8/2026Boost Price Target$44.79$52.00Buy$0.0000.00% ROICOGTCogent Biosciences1/6/2026Boost Price Target$34.26$52.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals12/22/2025Reiterated Rating$7.80$20.00Buy$0.0000.00% ROIBNTXBioNTech12/11/2025Reiterated Rating$96.00$140.00Buy$0.0000.00% ROINUVBNuvation Bio12/11/2025Boost Price Target$7.90$18.00Buy$0.0000.00% ROINRIXNurix Therapeutics12/10/2025Boost Price Target$19.55$31.00Buy$0.0000.00% ROINUVBNuvation Bio12/1/2025Reiterated Rating$8.05$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics11/20/2025Boost Price Target$9.10$26.00Buy$0.0000.00% ROIZYMEZymeworks11/18/2025Boost Price Target$23.90$32.00Buy$0.0000.00% ROIORICOric Pharmaceuticals11/14/2025Boost Price Target$13.08$23.00Buy$0.0000.00% ROICOGTCogent Biosciences11/13/2025Boost Price Target$35.26$50.00Buy$0.0000.00% ROIBNTXBioNTech11/10/2025Boost Price Target$103.14$140.00Buy$0.0000.00% ROIACETAdicet Bio11/7/2025Boost Price Target$10.83$144.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/6/2025Boost Price Target$59.34$73.00Buy$0.0000.00% ROICRBUCaribou Biosciences11/5/2025Boost Price Target$2.17$9.00Buy$0.0000.00% ROIEXELExelixis11/5/2025Boost Price Target$39.06$49.00Buy$0.0000.00% ROICOGTCogent Biosciences11/4/2025Reiterated Rating$15.50$21.00Buy$0.0000.00% ROIMGNXMacroGenics11/3/2025Reiterated Rating$1.66$2.00Neutral$0.0000.00% ROIFATEFate Therapeutics10/31/2025Upgrade$1.29$5.00Buy$0.0000.00% ROIZYMEZymeworks10/27/2025Reiterated Rating$17.87Buy$0.0000.00% ROINRIXNurix Therapeutics10/27/2025Lower Price Target$11.98$28.00Buy$0.0000.00% ROIREPLReplimune Group10/27/2025Upgrade$8.80$12.00Buy$0.0000.00% ROIRPTXRepare Therapeutics10/27/2025Lower Price Target$1.90$3.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Set Price Target$5.74$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/20/2025Reiterated Rating$9.84$33.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Initiated Coverage$5.86$7.00Buy$0.0000.00% ROIADCTADC Therapeutics10/16/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/14/2025Lower Price Target$9.72$33.00Buy$0.0000.00% ROIZYMEZymeworks10/14/2025Set Price Target$18.11$26.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics10/13/2025Upgrade$5.50$15.00Buy$0.0000.00% ROICATXPerspective Therapeutics10/3/2025Reiterated Rating$3.49$10.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics9/23/2025Reiterated Rating$1.01$5.00Buy$0.0000.00% ROINUVBNuvation Bio9/19/2025Reiterated Rating$3.16$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics9/19/2025Reiterated Rating$3.29$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/12/2025Reiterated Rating$6.62$24.00Buy$0.0000.00% ROIIMMXImmix Biopharma9/12/2025Boost Price Target$2.22$8.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals9/10/2025Lower Price Target$9.66$20.00Buy$0.0000.00% ROIBNTXBioNTech9/8/2025Reiterated Rating$112.46$136.00Buy$0.0000.00% ROIREPLReplimune Group9/8/2025Reiterated Rating$6.33Neutral$0.0000.00% ROIRLAYRelay Therapeutics8/26/2025Lower Price Target$3.51$14.00Buy$0.0000.00% ROIOKUROnKure Therapeutics8/26/2025Reiterated Rating$2.75$34.00Buy$0.0000.00% ROIBCAXBicara Therapeutics8/22/2025Lower Price Target$11.63$40.00Buy$0.0000.00% ROICGEMCullinan Therapeutics8/21/2025Initiated Coverage$7.47$24.00Buy$0.0000.00% ROIORICOric Pharmaceuticals8/14/2025Lower Price Target$9.83$19.00Buy$0.0000.00% ROIBNTXBioNTech8/14/2025Lower Price Target$111.87$136.00Buy$0.0000.00% ROIAVBPArriVent BioPharma8/12/2025Reiterated Rating$17.42$42.00Buy$0.0000.00% ROIEXELExelixis8/12/2025Lower Price Target$37.41$46.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics8/11/2025Lower Price Target$2.40$10.00Buy$0.0000.00% ROIYMABY-mAbs Therapeutics8/6/2025Reiterated Rating$8.52$8.60Neutral$0.0000.00% ROICOGTCogent Biosciences8/6/2025Lower Price Target$11.36$21.00Buy$0.0000.00% ROIIran War Shock: What I Was Told In That Private Meeting (Ad)You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.Because THIS is the real reason.CRDFCardiff Oncology8/6/2025Lower Price Target$2.57$10.00Buy$0.0000.00% ROIREPLReplimune Group7/23/2025Downgrade$2.81Neutral$00.0000.00% ROIACETAdicet Bio7/23/2025Upgrade$12.03$64.00Strong-Buy$0.0000.00% ROIAVBPArriVent BioPharma7/22/2025Reiterated Rating$21.55$40.00Buy$00.0000.00% ROIELTXElicio Therapeutics7/17/2025Boost Price Target$9.05$13.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics7/16/2025Downgrade$4.24Neutral$0.0000.00% ROINRIXNurix Therapeutics7/14/2025Lower Price Target$12.42$34.00Buy$00.0000.00% ROIKPTIKaryopharm Therapeutics7/11/2025Initiated Coverage$5.00$27.00Buy$00.0000.00% ROICOGTCogent Biosciences7/8/2025Boost Price Target$9.33$22.00Buy$00.0000.00% ROITLXTelix Pharmaceuticals7/3/2025Initiated Coverage$16.50$23.00Buy$00.0000.00% ROIZYMEZymeworks7/3/2025Reiterated Rating$12.89$13.00Neutral$00.0000.00% ROIREPLReplimune Group7/3/2025Reiterated Rating$9.55$22.00Buy$00.0000.00% ROIELVNEnliven Therapeutics7/2/2025Boost Price Target$19.65$48.00Buy$00.0000.00% ROIEXELExelixis6/30/2025Boost Price Target$43.67$53.00Buy$00.0000.00% ROIBNTXBioNTech6/25/2025Reiterated Rating$105.09$138.00Buy$00.0000.00% ROIBNTXBioNTech6/16/2025Lower Price Target$106.57$138.00Buy$00.0000.00% ROIEXELExelixis6/12/2025Reiterated Rating$41.43$47.00Buy$00.0000.00% ROIBNTXBioNTech6/5/2025Boost Price Target$111.21$145.00Buy$00.0000.00% ROIIMMXImmix Biopharma6/4/2025Reiterated Rating$2.11$7.00Buy$0.0000.00% ROIBNTXBioNTech5/22/2025Reiterated Rating$99.09$134.00Buy$00.0000.00% ROICOGTCogent Biosciences5/20/2025Lower Price Target$5.03$12.00Buy$00.0000.00% ROIYMABY-mAbs Therapeutics5/19/2025Lower Price Target$4.10$11.00Buy$0.0000.00% ROIELVNEnliven Therapeutics5/15/2025Boost Price Target$19.89$40.00Buy$00.0000.00% ROIRVMDRevolution Medicines5/14/2025Reiterated Rating$40.01$72.00Buy$000.0000.00% ROIBNTXBioNTech5/14/2025Reiterated Rating$93.89$134.00Buy$00.0000.00% ROIAVBPArriVent BioPharma5/14/2025Boost Price Target$18.76$40.00Buy$00.0000.00% ROICRDFCardiff Oncology5/9/2025Boost Price Target$2.63$18.00Buy$0.0000.00% ROIORICOric Pharmaceuticals5/5/2025Reiterated Rating$5.67$21.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics5/5/2025Reiterated Rating$0.89$5.00Buy$0.0000.00% ROICRBUCaribou Biosciences4/28/2025Reiterated Rating$0.77$3.00Buy$0.0000.00% ROITNGXTango Therapeutics4/14/2025Reiterated Rating$1.41$13.00Buy$00.0000.00% ROIPRLDPrelude Therapeutics4/8/2025Reiterated Rating$0.65$5.00Buy$0.0000.00% ROIELTXElicio Therapeutics4/2/2025Reiterated Rating$4.95$10.00Buy$00.0000.00% ROINRIXNurix Therapeutics4/2/2025Reiterated Rating$10.47$36.00Buy$00.0000.00% ROIBNTXBioNTech4/1/2025Lower Price Target$91.06$145.00Buy$00.0000.00% ROIADCTADC Therapeutics3/31/2025Reiterated Rating$1.49$8.00Buy$0.0000.00% ROIEXELExelixis3/27/2025Reiterated Rating$37.01$40.00Buy$00.0000.00% ROIMGNXMacroGenics3/25/2025Lower Price Target$1.96$2.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics3/21/2025Boost Price Target$20.92$39.00Buy$00.0000.00% ROIYMABY-mAbs Therapeutics3/21/2025Lower Price Target$4.92$12.00Buy$0.0000.00% ROIPMVPPMV Pharmaceuticals3/20/2025Reiterated Rating$1.28$5.00Buy$0.0000.00% ROIALLOAllogene Therapeutics3/19/2025Lower Price Target$1.69$8.00Buy$0.0000.00% ROICRBUCaribou Biosciences3/19/2025Reiterated Rating$0.95$9.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics3/18/2025Boost Price Target$1.71$12.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/13/2025Initiated Coverage$2.66$10.00Buy$0.0000.00% ROINUVBNuvation Bio3/10/2025Lower Price Target$2.03$10.00Buy$0.0000.00% ROIZYMEZymeworks3/10/2025Boost Price Target$11.09$13.00Neutral$00.0000.00% ROIRPTXRepare Therapeutics3/7/2025Lower Price Target$1.19$5.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/7/2025Reiterated Rating$3.48$16.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/7/2025Reiterated Rating$21.81$39.00Buy$00.0000.00% ROIYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesHURATuHURA Biosciences3/3/2025Initiated Coverage$2.41$13.00Buy$0.0000.00% ROIRVMDRevolution Medicines3/3/2025Boost Price Target$40.74$73.00Buy$000.0000.00% ROICRDFCardiff Oncology2/28/2025Boost Price Target$4.06$17.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/21/2025Reiterated Rating$7.63$21.00Buy$00.0000.00% ROIEXELExelixis2/13/2025Reiterated Rating$32.80$40.00Buy$00.0000.00% ROIREPLReplimune Group2/13/2025Boost Price Target$13.79$22.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/11/2025Reiterated Rating$11.23$21.00Buy$00.0000.00% ROIIMMXImmix Biopharma2/10/2025Reiterated Rating$2.01$7.00Buy$0.0000.00% ROICRGXCARGO Therapeutics1/30/2025Downgrade$13.19Neutral$0.0000.00% ROINRIXNurix Therapeutics1/29/2025Boost Price Target$19.56$36.00Buy$00.0000.00% ROIATRAAtara Biotherapeutics1/28/2025Reiterated Rating$7.37Neutral$0.0000.00% ROIEXELExelixis1/27/2025Reiterated Rating$32.38$40.00Buy$00.0000.00% ROINUVBNuvation Bio1/23/2025Boost Price Target$2.65$11.00Buy$0.0000.00% ROIATRAAtara Biotherapeutics1/22/2025Reiterated Rating$6.05Neutral$0.0000.00% ROIAVBPArriVent BioPharma1/22/2025Boost Price Target$25.31$39.00Buy$00.0000.00% ROIREPLReplimune Group1/22/2025Boost Price Target$11.85$21.00Buy$0.0000.00% ROICOGTCogent Biosciences1/14/2025Lower Price Target$7.57$14.00Buy$00.0000.00% ROIRLAYRelay Therapeutics1/14/2025Reiterated Rating$4.78$16.00Buy$0.0000.00% ROIYMABY-mAbs Therapeutics1/13/2025Reiterated Rating$6.89$22.00Buy$0.0000.00% ROIORICOric Pharmaceuticals1/13/2025Reiterated Rating$8.29$21.00Buy$0.0000.00% ROIEXELExelixis1/10/2025Boost Price Target$34.50$40.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
